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Abstract
Background: Antibodies of the IgG3 subclass have been implicated in the pathogenesis of the spontaneous
glomerulonephritis observed in mice of the MRL/MpJ-Tnfrsf6lpr (MRL/lpr) inbred strain which have been widely
studied as a model of systemic lupus erythematosus We have produced IgG3-deficient (-/-) mice with the MRL/lpr
genetic background to determine whether IgG3 antibodies are necessary for or at least contributory to MRL/lpr-
associated nephritis.
Results: The gamma3 genotype (+/+ vs. +/- vs. -/-) did not appear to significantly affect serum titers of IgG auto-
antibodies specific for double-stranded DNA (dsDNA) or a-actinin. However, while substantial serum titers of IgG3 auto-
antibodies specific for double-stranded DNA (dsDNA) or a-actinin were seen in gamma3 +/+ mice, somewhat lower
serum titers of these IgG3 auto-antibodies were found in gamma3 +/- mice, and gamma3 -/- mice exhibited baseline
concentrations of these auto-antibodies. Analysis of immunoglobulins eluted from snap-frozen kidneys obtained from
mice of all three gamma3 genotypes at ~18 weeks of age revealed much higher quantities of IgG in the kidneys from
gamma3 +/+ than gamma3 -/- mice, and most IgG eluted from +/+ mice was IgG3. The serum creatinine levels in
gamma3 +/+ mice substantially exceeded those of age-matched gamma3 -/- mice after ~21 weeks of age.
Histopathological examination of kidneys from mice sacrificed at pre-determined ages also revealed more extensive
glomerulosclerosis in gamma3 +/+ or +/- mice than in -/- mice beginning at 21 weeks of age. Survival analysis for IgG3-
deficient and IgG3-producing MRL/lpr mice revealed that gamma3 -/- mice lived significantly longer (p = 0.0006) than
either gamma3 +/- or +/+ mice. Spontaneous death appeared to be due to irreversible renal failure, because > 85% of
glomeruli in kidneys from mice that died spontaneously were obliterated by glomerulosclerosis.
Conclusions: The available evidence suggests that IgG3 deficiency partially protects MRL/lpr mice against
glomerulonephritis-associated morbidity and mortality by slowing or arresting the progression to
glomerulosclerosis.
Reviewers: This article was reviewed by Pushpa Pandiyan, Irun Cohen, and Etienne Joly.
Background
Mice of the MRL/MpJ-Tnfrsf6lpr (MRL/lpr)i n b r e d
strain are genetically predisposed to a spontaneous auto-
immune syndrome that resembles human systemic lupus
erythematosus (SLE or lupus) in several key features. As
in lupus patients, a major cause of morbidity and
mortality in both male and female MRL/lpr mice is pro-
gressive glomerulonephritis [1-3]. The pathogenic cas-
cade that culminates in renal damage in human and
mouse has been correlated with the renal deposition of
auto-antibodies, many of which exhibit specificity for
antigens that derive from cell nuclei [4].
Analysis of antibodies specific for auto-antigens or
those deposited in the affected kidneys has revealed that
IgG antibodies are the dominant isotype [5]. In terms of
IgG subclasses, there is evidence implicating both IgG2a
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in MRL/lpr mice [6]. Several distinct experimental
manipulations that decreased IgG3 production have
been associated with less severe renal disease in mice of
the MRL/lpr or other inbred strains prone to autoim-
mune disease [7-9]. Conversely, increased production of
IgG3 antibodies associated with expression of the Yaa
gene on the MRL background has been correlated with
more severe renal disease [7]. Similarly, genetic elimina-
tion of IgM secretion in the MRL/lpr background was
associated with increased titers of serum auto-antibodies
o ft h eI g G 3( a sw e l la st h eI g G 1a n dI g G 2 as u b c l a s s e s )
specific for dsDNA and more severe glomerulonephritis
and earlier mortality [10]. In all cases, these perturba-
tions likely generated potentially relevant physiologic
effects other than altered concentration of IgG3 antibo-
dies in serum. Although passive transfer of substantial
amounts of IgG3 monoclonal antibodies with rheuma-
toid factor activity can elicit renal pathology analogous
to the damage that develops spontaneously in MRL/lpr
mice [11-14], the serum levels of such antibodies
required for these effects may surpass those that are
physiologically relevant in the spontaneous disease.
In the course of characterizing the J606 myeloma protein,
the first identified murine IgG3 antibody, the investigators
noted that the J606 Fc regions tended to self-associate at
concentrations in the mg/ml range [15]. Subsequent
reports revealed that a notable characteristic of many IgG3
antibodies is to self-associate in antigen-independent
[16-20] or antigen-dependent [21-24] contexts, the latter at
much lower antibody concentrations. We hypothesized
that Fc-Fc interaction between IgG3 molecules confers a
greater effective valence, and thereby greater functional
affinity, permitting antibodies with relatively modest intrin-
sic (i.e., per site) affinities to bind effectively to highly mul-
tivalent antigens [21]. This physical-chemical phenotype,
unique among the mouse IgG subclasses, has been rationa-
lized [25] with reference to the remarkable association
between IgG3 production and immunization with polysac-
charide (or, less commonly, protein) antigens bearing mul-
tiple copies of the same epitope [26].
Previous studies with IgG3-deficient mice of the
BALB/c background demonstrated that such mice were
more susceptible to mortality following pneumococcal
infection than wild-type BALB/c mice [27]. These mice
were also less effectively protected by a vaccine consist-
ing only of the relevant pneumococcal capsular polysac-
charide. Overall, the results were suggestive of a unique
role for IgG3 in protecting against encapsulated bacter-
ial pathogens and were consistent with the possibility
that cooperative binding (via Fc-Fc interactions) of IgG3
antibodies to bacterial capsular polysaccharides is critical
to the mediation of immunity.
Irrespective of the potentially beneficial conse-
quences of antibody self-association, there are reasons
to wonder if the unusual physical properties of IgG3
antibodies have any potentially negative consequences
in vivo. In addition to the circumstantial evidence,
recounted above, implicating antibodies of the IgG3
subclass in the pathogenesis of glomerulonephritis in
murine models of lupus, antibody aggregation has long
been regarded as a possible cause of inflammation and
tissue damage [28]. It is of interest, in this context,
that IgG3 is typically present at a lower concentration
in serum than the other IgG subclasses (IgG1, IgG2a,
a n dI g G 2 b )[ 2 9 ] .
Therefore, to address more definitively the importance
of IgG3 antibodies in the spontaneous renal disease of
MRL/lpr mice, we sought to assess the consequences of
genetic deficiency in the capacity to synthesize IgG3
antibodies. In this report, we compare titers of serum
auto-antibodies to dsDNA and a-actinin, renal deposi-
tion of auto-antibodies, renal function, kidney histo-
pathology, and survival among mice of the three g3
heavy chain genotypes: +/+, +/-, and -/-.
Results
Congenic status of g3 deficient mice
IgG3-deficient mice possessing the genetic background of
the MRL/MpJ-Tnfrsf6
lpr (MRL/lpr) inbred strain were cre-
ated through 12 generations of backcrossing mice carrying
the defective g3 heavy chain constant region gene [30] to
mice of the MRL/lpr strain. Mice of all three g3h e a v y
chain constant region genotypes (+/+, +/- and -/-) were
generated by crosses between heterozygotes or crosses
between g3 +/- and either -/- or +/+ mice. Figure 1 pro-
vides representative genotyping results for the g3 -/-, +/-,
and +/+ mice, and Figure 2 documents the absence of
detectable serum IgG3 by immunoblot in g3 -/- mice.
Two hundred SNPs were typed by single base exten-
sion reactions and sequencing by Jax Services (Bar Har-
bor, ME) for each of six mice typed by us as g3-
deficient. Of the 200 SNPs typed, 199, on chromosomes
1-19, were determined to be of MRL/lpr origin for six
of six mice (data not shown). One SNP, located on the
distal end of chromosome 12 near the g3 heavy chain
constant region locus, was typed as of donor origin in
each mouse. A chromosome 12 locus, sbb2, identified
by Bolland et al. [31] as a site for allelic variation that
influences autoimmunity, lies approximately 100 Mbp
from the targeted Ig heavy chain locus. In all of our
tested mice, this sbb2 locus is flanked on both sides by
SNPs of MRL/lpr origin. Similarly, the Fas locus on
chromosome 19 is surrounded on both sides by SNPs of
MRL/lpr origin, strongly suggesting that the g3- / -m i c e
have the lpr Fas allele.
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spleen was performed by flow cytometry. This analysis
provided an additional test of the success of the backcross-
ing, as mice of the MRL/lpr strain are known to contain
significant numbers of cells exhibiting a T cell phenotype
(CD3
+,C D 4
-,C D 8
-) that is unusual for cells in the periph-
ery in other mouse strains. As revealed in Figure 3, the
MRL/lpr g3 -/- mice also have these cells in numbers
roughly comparable to the +/+ and +/- mice, consistent
with an authentic MRL/lpr genetic background.
Auto-antibodies specific for dsDNA and a-actinin
Titers of serum auto-antibodies with specificity for dsDNA
and a-actinin were determined by ELISA using samples
from four month-old mice of all three g3 genotypes (Fig-
ure 4). The serum titers of IgG auto-antibodies with speci-
ficity for dsDNA were somewhat higher in g3 +/+ and +/-
than in -/- mice (F = 6.0, t ≥ 2.6, p < 0.02), but IgG specific
for a-actinin did not differ among the groups statistically.
However, there were large and statistically significant ( F ≥
30.0, t ≥ 3.3, p < 0.01) differences in the serum IgG3 titers
for both dsDNA and a-actinin antibodies according to g3
genotype (Figure 4). These differences establish that
whereas significant titers of IgG3 auto-antibodies specific
for both dsDNA and a-actinin were present in g3 +/+ and
(to a lesser extent) +/- mice, titers for these antibodies
were at baseline levels in the g3 -/- mice. The greater con-
centration of the IgG3 auto-antibodies in the IgG3 produ-
cing mice could contribute to any observed g3 genotype-
associated differences in renal function, renal histopathol-
ogy, and survival (see below).
A
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Figure 1 Polymerase chain reaction (PCR)-based genotyping of
representative progeny of a cross between g3 +/- mice.A .
Schematic of PCR primers used for genotyping: primers for wild-
type g3 allele, blue arrows; primers for defective g3 allele, red
arrows. B. Results for mice representing all three g3 genotypes (w:
+/+; k: -/-; h: +/-). The band produced by the primers for the wild-
type (+) g3 allele is 750 base pairs (bp), and the band produced by
the primers for the disrupted (knockout or -) g3 allele is 628 bp. m
-size markers.
1  2  3   4   5  6   7   8   9  10 
61 0kDa 61.0kDa
47.8kDa
Figure 2 Western blot for g3 heavy chain (IgG3) in serum from
mice bearing zero (-/-), one (+/-), or two (+/+) wild-type
(functional) g3 heavy chain alleles by PCR genotyping assay.
Lane 1, markers; 2-6, g3 +/+; 7-8, g3 +/-; 9-10, g3 -/-.
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Figure 3 Relative numbers of T-lymphocyte subsets based on
cell surface expression of standard subset markers by flow
cytometry applied to spleen cells from MRL/lpr mice at 3
months of age and age-matched controls of a strain (C3H)
without an obvious predisposition to lupus-like disease.
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Eluates from the kidneys of g3 +/+ mice contained more
IgG (16.8 or 86 μg/ml at 18 or 21 weeks of age, respec-
tively) than those from -/- mice (6 or 66 μg/mL, respec-
tively). As expected, the IgG3 concentrations in eluates
from g3 +/+ mice far exceeded those in -/- mice (data
not shown). Most (> 80%) of the IgG antibodies suscep-
tible to elution from the +/+ kidneys at 21 weeks were
IgG3 subclass, and the increased IgG content in renal
eluates from +/+ mice at 21 versus 18 weeks of age was
almost exclusively of the IgG3 subclass. In contrast, <
12% of the IgG in eluates from -/- mice was IgG3. The
eluates from +/- mice were between these extremes, but
IgG3 represented only ~10% of the total IgG eluted
from +/- mice at either age. Overall, there is consider-
ably more IgG deposited in +/+ than in -/- kidneys, and
IgG3 antibodies are a significant fraction of the IgG
eluted from the +/+ mice at 21 weeks.
Renal function over time related to genotype
All mice, regardless of the g3 genotype, exhibited patho-
logic and heavy proteinuria throughout the period of
timed sacrifices (data not shown). Urinary protein excre-
tion increased from 2.7, 0.8 or 1.7 mg/d in the g3+ / + ,
+/- and -/- mice, respectively, at 18 weeks of age to
15.3, 7.4 or 7.6 mg/d in the respective groups at 26
weeks. As a more standardized measure of glomerular
permselectivity, the ratio of protein to creatinine in
urine exhibited a similar pattern, exceeding 15 in +/+
mice at all times points observed, while increasing from
4.58 to 21.1 in +/- and from 5.5 to 11.9 in -/- mice (Fig-
ure 5). The sharp rise in urinary protein:creatinine ratio
observed in g3 +/+ from 18 to 21 weeks and in +/- mice
from 21 to 26 weeks was due in part to reduced creati-
nine excretion, whereas the sustained glomerular filtra-
tion in -/- mice (with minor glomerulosclerosis, see
below) supported a more gradual increase in the urinary
protein:creatinine ratio. In fact, at 26 weeks of age, urin-
ary creatinine was only 0.14 and 0.21 mg/d in +/+ and
+/- mice, respectively, but remained at 0.29 mg/d in g3
-/-, mice. Although the g3 +/+ mice had a significantly
higher protein:creatinine ratio than the +/- or -/- mice
at 18 and 21 weeks, the differences among the groups at
26 weeks were not statistically significant. Consonant
with diminished urinary creatinine excretion, and pre-
sumably a decline in the glomerular filtration rate, urine
Figure 4 Serum auto-antibody activity for dsDNA or a-actinin
assessed by ELISA. Serum samples from g3 +/+ (green), +/-
(yellow), and -/- (red) mice were tested for binding of total IgG (left
panel) to double stranded (ds) DNA (circles) or to a-actinin
(squares), and for binding of IgG3 (right panel) to dsDNA
(diamonds) or to a-actinin (triangles).
Figure 5 Urinary protein:creatinine ratio as a function of age in
mice of the three MRL/lpr g3 heavy chain genotypes. All mice,
regardless of the g3 heavy chain genotype, exhibited pathologic
and heavy proteinuria throughout the observation period. The
mean urinary protein:creatinine ratio exceeded 15 at all time points
observed in +/+ mice (green squares), whereas it increased from
4.58 to 21.1 in +/- mice (yellow diamonds) and from 5.5 to 11.9 in
-/- mice (red circles).
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tained at relatively normal values in g3 -/- mice over the
period of timed sacrifice (data not shown).
Perhaps most cogently, the serum creatinine concen-
tration rose sharply and progressively in g3+ / +m i c e
over the interval of observation (Figure 6), to a level
that was significantly (F = 6.8) higher than that in g3- / -
mice at 26 weeks (t = 3.02, p < 0.01,). Serum creatinine
in both the +/+ and +/- mice at 26 weeks was signifi-
cantly (t > 3.6, p < 0.01) higher than the level in the
same genotype at 18 weeks, whereas the difference in
serum creatinine between 18 and 26 week old -/- mice
was less pronounced and did not reach statistical signifi-
cance (t = 2.2). These data indicate that there was pro-
gressive renal insufficiency (and presumably nephron
loss) in the mice capable of producing IgG3, but this
process was attenuated in -/- mice. On the other hand,
all three genotypes had similar mean serum creatinine
values (of ~1.15 ± 0.11 mg/dl) at 18 weeks of age, which
is markedly elevated over normal serum creatinine
values (< 0.6 mg/dl) in several different mouse strains.
Serum creatinine levels in +/- mice were intermediate
between the two homozygous groups, but did not differ
statistically from either of the other two genotypes at
any time point. Overall, the results are consistent with
IgG3 subclass antibodies contributing significantly to
the deterioration of renal function over time.
Renal histopathology over time related to genotype
Histopathologic examination of kidneys from mice of all
three g3 genotypes, sacrificed at selected ages (18, 21,
and 26 weeks), also suggests that the absence of IgG3
antibodies influences survival by altering the progression
of glomerular damage. Specifically, mice of all three gen-
otypes at 18 weeks of age had a minority of glomeruli
with no or only minor mesangial lesions (Figure 7A),
and a large majority that exhibited acute endocapillary
proliferative glomerulonephritis (Figures 7B and 7C); the
frequency of abnormal glomeruli was equal among the
genotypes (Figure 8A). By 21 weeks of age, most glo-
meruli in g3 +/+ and +/- mice showed chronic changes
in glomerular basement membranes superimposed upon
sustained endocapillary hypercellularity (Figures 7D and
7E), whereas the g3 -/- mice exhibited mostly acute
lesions, similar to those seen at 18 weeks. At 26 weeks
of age, g3 +/+ and +/- mice progressed to extensive glo-
merular sclerosis (Figures 7F and 8B). The g3 -/- mice
exhibited a dramatically lower incidence of irreversible
destruction of glomeruli (Figure 8B, F = 39.3, p <
0.001).; instead, the majority of the glomeruli in these
mice revealed chronic endocapillary hypercellularity
(Figures 7D, E, and 8A). Thus, while the g3- / -m i c e
clearly suffer renal damage, the process of progression
to end stage renal disease appears to be retarded or
arrested.
In both human and murine glomerulonephritides
associated with lupus or lupus-like disease, glomerular
crescents, tubulointerstitial inflammation and interstitial
fibrosis are frequent concomitants. A minority of the
glomeruli in the mice examined in this work exhibited
small crescents, principally cellular at 18 or 21 weeks of
age, but mixed fibrocellular or fibrous changes at 21 or
26 weeks of age. The overall frequency and size of the
crescents did not differ significantly among the geno-
types at any age. Whereas the character of crescents in
g3 +/+ and +/- mice shifted from cellular to increasingly
fibrous collaterally with increased age and increased
incidence of glomerulosclerosis, fibrous crescents were
unusual in g3 -/- mice, even at 26 weeks old (data not
shown). Kidneys from most mice exhibited patchy lym-
phohistiocytic infiltrates within the tubulointerstitium,
and the frequency of such involvement did not differ
among genotypes. However, the extent of the interstitial
infiltrates and the appearance of tracts of interstitial
fibrosis were closely correlated to the extent of glomeru-
losclerosis, as is typically the case in spontaneous lupus
Figure 6 Serum creatinine as a function of age in mice of the
three MRL/lpr g3 heavy chain genotypes. The serum creatinine
increased early (by 21 weeks) during the course of disease in +/+
mice (green squares), whereas -/- mice (red circles) exhibited a
more gradual course, with levels of serum creatinine significantly
less than in +/+ mice at 21 and 26 weeks. The +/- (yellow
diamonds) mice followed an intermediate course.
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merulonephritis. Therefore, the extent of interstitial
inflammation and the extent of interstitial fibrosis were
both significantly greater in g3 +/+ and +/- mice than in
the -/- littermates (data not shown).
Mortality
Analysis of the survival of the first two birth cohorts of
MRL/lpr mice, including littermates of all genotypes,
revealed that g3 +/+ (n = 28) and +/- (n = 42) mice
died at significantly younger ages than g3 -/- (n = 16)
mice (p = 0.0006, Figure 9). Similar patterns of differen-
tial survival were observed in both cohorts analyzed
separately (p = 0.003 and 0.006, respectively). The survi-
val curves of male versus female mice (of all three geno-
types combined) overlap extensively, indicating that
gender has no effect on survival (data not shown). The
lifespan of g3 +/+ mice and the lack of a gender effect
on survival of the back-crossed mice used herein
resemble closely features of the parental MRL/lpr strain,
and further support the assumption that the mice
reported in this communication are of authentic MRL/
lpr genetic background.
The leading cause of mortality in MRL/lpr mice is
renal failure [1-3]. In accord with these earlier observa-
tions, kidneys removed from g3 +/+ and +/- mice dying
spontaneously revealed extensive (> 85%) glomerulo-
sclerosis. Two of a total of three g3 -/- mice dying spon-
taneously were retrieved for histologic examination of
the kidneys. One of these had extensive (73%) glomeru-
losclerosis, whereas the other mice had diffuse endoca-
pillary proliferative glomerulonephritis, with only a
minor (28%) extent of glomerulosclerosis.
Discussion
The conventional interpretation of the pathogenesis of
lupus nephritis, in man or mouse, is that IgG auto-anti-
bodies deposit in the kidney in the form of immune
Figure 7 Representative histopathology for mice of the three MRL/lpr g heavy change genotypes. At 18 weeks of age, a small minority
(~12%) of the glomeruli in each genotype appeared normal (panel A). The most prevalent glomerular pattern (66-76% of glomeruli) at 18 weeks
in mice of all three g3 heavy chain genotypes was segmental (panel B) or global (C) acute endocapillary proliferative glomerulonephritis, wherein
some or most glomerular capillaries are narrowed by increased numbers of cells (blue arrows), without changes in the glomerular basement
membranes. In g3 -/- mice at 26 weeks of age, and in g3 +/+ and +/- mice at 21 weeks of age, chronic endocapillary proliferative
glomerulonephritis (panel D, from a g3 -/- mouse at 26 weeks, and panel E, from a g3 +/- mouse at 26 weeks) was most prevalent; in these
glomeruli, thickening and tortuosity of basement membranes (red arrowheads) is superimposed upon persistently increased endocapillary
cellularity (blue arrows). Sclerosis, characterized by collapse, marked thickening and tortuosity of glomerular basement membranes, that occludes
capillary lumens and distorts glomerular architecture (panel F), was the most prevalent pattern (67-79%) in glomeruli in +/+ and +/- mice at 26
weeks. In contrast, scarring evident as irreversible glomerulosclerosis was relatively infrequent (≤ 22%) in -/- mice at all time points.
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[4,32]. In the case of lupus-prone mouse strains, sub-
stantial circumstantial evidence has implicated antibo-
dies of both the IgG2a and IgG3 subclasses in the
pathogenesis of glomerulonephritis leading to renal fail-
ure [6-9,11-14,33].
While the evidence implicating IgG3 antibodies in the
pathogenesis of the spontaneous glomerulonephritis in
MRL/lpr mice is substantial, it is not definitive. None of
the reported perturbations that affect both the serum
levels of IgG3 and the incidence or severity of glomeru-
lonephritis influence only serum IgG3 concentrations.
Therefore, the goal of the proposed studies was to
define more precisely the role of antibodies of the IgG3
subclass in MRL/lpr renal disease by directly comparing
IgG3-producing (g3+ / -a n d+ / + )t oI g G 3 - d e f i c i e n t( g3
-/-) mice of the MRL/lpr background. The current ana-
lysis was undertaken with the recognition that even
after twelve generations of backcrossing to minimize the
chances of cryptic but relevant genetic differences
between IgG3-deficient (g3 -/-) and IgG3-producing (g3
+/- and +/+) mice of the MRL/lpr background, there
remains some finite, if low, probability of such allelic
disparities [34]. Therefore, to the extent possible, we
have compared MRL/lpr mice of the three genotypes
deriving from the same litters of crosses between g3 het-
erozygotes. Genetic analysis of single nucleotide poly-
morphisms at 200 loci on chromosomes 1-19 (data not
shown) strongly suggested that donor origin DNA was
restricted to the distal end of chromosome 12 near the
g3 heavy chain constant region locus. Furthermore, the
biologic behavior of the g3 +/+ mice resembled closely
that of mice of the parental MRL/lpr strain in several
characteristic features.
While the presence of two defective g3 heavy chain
constant region alleles did not greatly reduce the titers
Figure 8 Morphologic features as a function of age in mice of
the three MRL/lpr g3 heavy chain genotypes. The percentage of
renal glomeruli exhibiting either endocapillary proliferative
glomerulonephritis (A, top panel) or glomerulosclerosis (B, bottom
panel) is plotted as a function of age for mice of each genotype. In
+/+ mice (green squares) and +/- mice (yellow diamonds), there is
marked loss of functional glomeruli (with endocapillary proliferation)
by 26 weeks, with a reciprocal gain in irreversibly scarred glomeruli.
In contrast, -/- mice (red circles) exhibit sustained endocapillary
proliferative glomerulonephritis as late as 26 weeks, whereas the
fraction of scarred glomeruli is only minimally increased.
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was associated with highly significant reductions in IgG3
auto-antibodies specific for dsDNA and a-actinin. Per-
haps the most crucial point is that g3 +/+ mice, and to
a lesser extent +/- mice, exhibit substantial serum titers
of these IgG3 auto-antibodies that could contribute to
progressive kidney damage, whereas in g3 -/- mice such
progression is diminished. If the auto-antibodies of the
IgG3 subclass effectively contribute to scarring of kidney
tissue, then this difference in the concentrations of these
antibodies could account for the observed differences
among the mice of the three g3 heavy chain constant
region genotypes. The results from the kidney elution
studies are also generally supportive of the importance
of IgG3 antibodies in mediating the destruction of func-
tional renal tissue in g3 +/+ mice.
The mechanism(s) by which IgG3 antibodies might
contribute to the pathogenesis of glomerulonephritis
were not directly addressed in the present study. Addi-
tional investigation will be necessary to determine the
relative importance of direct versus indirect pathways in
the mediation of tissue damage by IgG3 antibodies.
Observations indicating that both IgG2a and IgG3 anti-
bodies are contributory to kidney disease raise the possi-
bility that IgG3 rheumatoid factors (i.e. antibodies able
to bind to IgG Fc regions), which can exhibit specificity
for IgG2a Fc regions and are present at high frequency
in MRL/lpr mice [16,17], exacerbate the inflammatory
stimulus created by the renal deposition of IgG2a anti-
bodies. The dual presence of IgG2a and IgG3 antibodies
in affected kidneys suggests the possible importance of
interferon gamma in the pathogenesis of the kidney dis-
ease, as this cytokine can enhance production of antibo-
dies of both subclasses [35,36]. Another mechanism that
may be operative alone, or in concert with rheumatoid
factor activity of IgG3 antibodies, relates to the effects
that self-association of IgG3 molecules might exert on
effective valence and functional affinity. Increased avid-
ity, or functional affinity, of the antibody component of
immune complexes increases the likelihood of com-
plexes to deposit and especially to persist within glomer-
ular capillary walls, independently of other properties of
the antibodies or immune complexes [37-39]. In turn, a
prolonged dwell time of immune deposits in the glomer-
uli might promote the increased production of constitu-
ents of the basement membrane, leading to more
extensive sclerosis and accelerated irreversible destruc-
tion of functioning nephrons.
Among mice sacrificed at defined ages, the glomerular
pathology in g3 +/+ and +/- mice evolved from endoca-
pillary proliferation to frank sclerosis far more fre-
quently than in g3 -/- mice. Histopathologic
examination of kidneys recovered from mice dying
spontaneously is also consistent with the notion that the
absence of IgG3 antibodies attenuates the irreversible
renal damage associated with the MRL/lpr mouse strain.
Nevertheless, it is also clear that even in the absence of
IgG3 production, kidney damage ensues, as reflected in
endocapillary proliferation.
The comparison of the g3 +/+, +/- and -/- mice with
respect to long-term survival revealed dramatic, and
highly statistically significant differences between either
+/+ or +/- and -/- mice (p = 0.0006) in the average age
of mortality. These results are reasonably, and most sim-
ply, interpreted as suggesting that antibodies of the IgG3
subclass contribute significantly to the more rapid mor-
tality of the g3 +/+ and +/- mice by causing the immune
complex-mediated renal disease to progress to end stage
renal failure. Given the SNP typing, the nearly identical
mortality curves for male and female mice of all g3g e n -
o t y p e s ,a n dt h ep r e s e n c ei nt h eg3 -/- mice of the unu-
sual CD3+, CD4-, CD8- lymphoid population that
characterizes MRL/lpr +/+ mice, we believe that the g3
-/- mice have an authentic MRL/lpr background, and
that it is very unlikely that an unidentified allelic differ-
ence between +/+ (or +/-) and -/- mice accounts for the
phenotypic differences described herein.
Finally, it is of interest to note that the g3 heavy chain
constant region locus has yet to be associated with the
murine lupus phenotype in genetic screening [40-42].
This failure to connect the g3 heavy chain-bearing anti-
bodies with the disease process may be reflective of a
potential, but insufficiently appreciated, weakness of
genomic screening approaches. Genome-wide or more
focused screens for disease-associated alleles assume
that any gene products involved in a pathogenic process
will be encoded at polymorphic loci such that some, but
not all, allelic products at the relevant locus or loci will
be participants in the disease process (or at least will be
substantially more contributory than alternative alleles).
The g3 heavy chain constant region gene is the most
conserved heavy chain constant region gene in the
mouse, and therefore, it may be rendered invisible in
gene-disease association studies using standard inbred
mouse strains, within which there may be no, or only
very limited, polymorphism. Nevertheless, as in the pre-
sent study, the lack of naturally-occurring disease-influ-
e n c i n gp o l y m o r p h i s m sa tal o c u sd o e sn o tp r e v e n tt h e
gene product encoded at that locus from contributing to
a pathogenic process. This is a particularly important
consideration in light of the observations reported in
this study, because progression of lupus nephritis, rather
than the incidence of the renal disease, varies with the
g3 -/- genotype.
Conclusions
Antibodies of the IgG3 subclass contribute to the spon-
taneously occurring glomerular disruption and
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strain but are not the sole contributors to this renal tis-
sue damage. In the absence of such antibodies, kidney
disease still occurs but, on average, fails to progress to
the same extent as in mice able to produce IgG3 antibo-
dies. These results also demonstrate that gene products
encoded at loci at which there are no naturally-occur-
ring disease-associated allelic variants can nevertheless
contribute significantly to disease pathogenesis.
Methods
Genotypes of mice
Experimental animals were maintained in an AAALAC
International-approved and specific pathogen-free facil-
ity, and used in accord with the protocol approved by
the IACUC at Case Western Reserve University. Mice
bearing a defective g3 heavy chain constant region gene
on a mixed 129 and C57BL6/J [30] or a BALB/c back-
ground [27] have been described. The IgG3-deficient
BALB/c mice were used to initiate 12 generations of
backcrossing of the defective g3 heavy chain constant
region gene onto the MRL/MpJ-Tnfrsf6lpr (MRL/lpr)
background. Female and male MRL/lpr mice used for
the backcrossing were obtained from The Jackson
Laboratory (Bar Harbor, ME). Mice of all three g3 heavy
chain constant region genotypes were then bred at
Taconic Farms (Germantown, NY) for the present
study. Genotyping was done in our lab (Figure 1) using
a polymerase chain reaction (PCR)-based assay with the
following forward and reverse primers:
1. CH1-up: tcaaacctagctgctaattc
2. CH1-down: tggatatgatcattgacagg
3. NEO 2: cttgggtggagaggctattc
4. NEO 3: caacgctatgtcctgatagc
Genomic SNP analysis
Tail samples from six MRL/lpr g3 -/- mice were sub-
mitted to Jax Services (Bar Harbor, ME) for genomic
single nucleotide polymorphism (SNP) typing, with 200
S N P s ,b ys i n g l eb a s ee x t e n s i o nr e a c t i o n sa n d
sequencing.
Western blot
Immunoblots for serum IgG3 were performed using
samples from MRL/lpr g3 +/+, +/- and -/- mice as
described [43]. The IgG3-specific reagent was an alka-
line phosphatase-conjugated goat polyclonal antibody
(Southern Biotechnology, Birmingham, AL) diluted
1:1,000.
Flow cytometry
Spleens from 3 month-old MRL/lpr g3 +/+, +/-, and -/-
mice and C3H control mice were processed into single-
cell suspensions for analysis by flow cytometry. We used
the following antibodies to mouse T cells: a cocktail of
anti-CD3epsilon-PE-Cy7, anti-CD4-PE, anti-CD8alpha-
APC, (BD Biosciences, Sparks, MD). Mouse B cells were
identified by anti-CD19-PE (eBioscience, San Diego,
CA). A multi-laser flow cytometer, BD LSR (BD Bios-
ciences), was used to analyze about 1 × 10e6 cells per
spleen sample. Isotype-matched control antibodies were
used in all analyses.
Measure of auto-antibodies specific for double-stranded
(ds) DNA and a-actinin
Concentrations of serum antibodies specific for dsDNA
or a-actinin were measured by ELISA as described
[44-46]. Briefly, dsDNA (Calbiochem Novabiochem, La
Jolla, CA) was purified by filtration through a 0.45-μm
filter (Millipore, Bedford, MA) to eliminate contaminat-
ing single-stranded DNA, and adsorbed to Immulon II
96-well microtiter plates (Dynatech Laboratories, Chan-
tilly, VA) at a concentration of 100 μg/ml in PBS; plates
were dried overnight at 37°C. Before blocking, excess
DNA was removed with a 4 min soak in distilled water.
Alternately, a-actinin (Sigma-Aldrich, St. Louis, MO) at
a concentration of 20 μg/ml was coated onto the same
plates overnight at 4°C. Plates were blocked with 3%
FCS for 1 h at 37°C and incubated with monoclonal
antibodies or serum at a 1/200 dilution for 2 h at RT.
Plates were washed five times with PBS-Tween, and
alkaline phosphatase-conjugated goat anti-mouse IgG or
goat anti-mouse IgG3 (both from Southern Biotechnol-
ogy Associates, Birmingham, AL) diluted 1/1000 in 3%
FCS was added for 1 h at 37°C. Both ELISAs were
developed by adding the alkaline phosphatase substrate
p-nitrophenyl phosphate (Sigma), and the OD was mon-
itored at 405 nm using a MRX Revelation ELISA Reader
(DYNEX Technologies, Chantilly, VA).
Elution of antibodies from kidneys
One-half of a snap-frozen kidney from each mouse was
thawed and minced with a clean razor blade. Kidneys
from mice of a given cohort were pooled, and Ig was
eluted [47]. The eluates were dialyzed at 4°C against dis-
tilled water for 24 hours and then against phosphate
buffered saline for an additional 24 hours. The amounts
of eluted IgG or IgG3 in each group were determined
by ELISA, and the antigenic specificities of the eluted
antibodies were measured by antigen-specific ELISAs, as
described [44,45]. This experiment was performed only
once.
Evaluation of renal function
Randomly selected mice of all three genotypes were
sacrificed by exsanguination under ether anesthesia at
approximately 18, 21 or 26 weeks of age (within a win-
dow of 3 days); serum and kidney tissue were harvested.
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placed into metabolic cages for collection of urine sam-
ples over ~16 hours. Proteinuria was quantified by a
proprietary protein assay kit (Bio-Rad Laboratories, Her-
cules, CA) based on a dye-binding procedure [48] in a
microplate. The protein concentrations in duplicate
urine samples were computed by interpolation of the
sample optical densities into a linear calibration curve
generated with purified bovine serum albumin (Sigma)
over a range of 0 to 1 mg/mL. The creatinine concen-
tration in serum or urine samples was determined by a
modified kinetic picric acid binding method [49]
adapted for micro-samples as we reported previously
[50]. Briefly, alkaline picrate was prepared by adding 5
parts of a proprietary solution of 0.6% picric acid in
sodium borate and surfactants (Sigma) to 1 part 1 N
NaOH. Next, 20 μL of standard or sample was added to
200 μL of alkaline picrate solution in duplicate micro-
wells. After 10 min at room temperature, the optical
density at 490 nm was recorded in a microplate reader.
Next, 10 μL of a 2:3 dilution of a proprietary mixture of
sulfuric and acetic acids (Sigma) in distilled water was
added to each well. Finally, after an additional incuba-
tion for 8 min at room temperature, the optical density
at 490 nm was again recorded. The difference between
the first and second absorbance readings for each sam-
ple was used for interpolation into a line correlating the
difference in optical density at the two times to standard
creatinine concentrations ranging from 0 to 3 mg/dL.
Evaluation of renal structure
Upon sacrifice (at specific ages selected to provide
insight into the progression of the renal disease) or dis-
covery of spontaneous death, each kidney was removed
and divided in the transverse plane into three portions.
The central portion of each kidney was fixed by immer-
sion in 10% neutral buffered formalin, dehydrated
through a graded series of ethanol solutions to anhy-
drous, washed twice in xylene, and infiltrated with mol-
ten paraffin (all reagents from Fisher Scientific,
Pittsburgh, PA) in an automated tissue processor (Auto-
Technicon, Tarrytown, NY). Tissue blocks were
embedded into molten paraffin, sectioned at 2 μmi na
Leica microtome, and stained with periodic acid-Schiff
reagent with a hematoxylin counterstain. Sections were
coded to prevent observer bias, and evaluated by a renal
pathologist.
Survival analysis
D u r i n gt h es u r v i v a ls t u d y ,m i c ew e r eo b s e r v e dt w i c e
daily, at 7 am and 6 pm; any mice found dead were
removed from the appropriate cages. The identifying
number of each dead mouse was recorded along with
the date and time of death, and kidneys were removed
and processed for histological examination as detailed
above.
Statistical analysis
Quantitative data from timed sacrifices (proteinuria,
urine creatinine excretion, serum creatinine concentra-
tion, and the fraction of glomeruli with each of several
histologic features) were evaluated by two-way analysis
of variance, considering the genotype and age of each
mouse at sacrifice as independent variables. The signifi-
cance of inter-group variation was evaluated by Bonfer-
roni’s t - statistic. Data were pooled from two
independent experiments, because three-way analysis of
variance disclosed that there was no significant differ-
ence between the two replicate experiments.
Overall survival was measured from the date of birth
to date of death, and censored at the date of last follow-
up for survivors or at the date of sacrifice. (A small
number of mice entered into the survival series were
sacrificed when moribund for analysis of renal histol-
ogy.) The differences among groups were tested using
the log rank test, and the Cox proportional hazards
model [51,52] was used to determine whether genotype
is associated with survival after adjusting for any effect
of sex. Before applying the Cox model, the proportional
hazard assumption was examined. All tests were two-
sided and p-values less than 0.05 were regarded as
significant.
Reviewers’ comments
Reviewer 1, Pushpa Pandiyan
In the manuscript titled “IgG3 Deficiency Extends Life-
span and Attenuates Progression of Glomerulonephritis
in MRL/lpr Mice”, Greenspan et al., have studied the
role of IgG3 antibody in the autoimmunity associated
with MRL/lpr mice. Although IgG3 antibodies are impli-
cated in autoimmunity, their definitive role in causing
immunopathology is unclear. These authors have gener-
ated IgG3 deficient mice and have shown that the loss
of IgG3 protects mice against glomerulonephritis-asso-
ciated morbidity and mortality. The authors deserve
credit for the well-controlled experiments using MRL/
lpr mice with all three genotypes derived from the same
litters of crosses between heterozygotes. They also
deserve credit for presenting their data clearly. The
authors have shown that although IgG3 deficient MRL/
lpr mice suffer renal damage, the process of progression
to end stage renal disease is retarded or arrested,
thereby increasing their survival, compared to normal
MRL/lpr mice. While these evidence imply that IgG3
antibodies play a pathogenic role in MRL/lpr mice, they
are not conclusive. To further strengthen the studies in
elucidating the role of IgG3, they should experimentally
demonstrate that passive transfer of IgG3 antibodies
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secreting IgG3 antibodies causes pathology or at least
decreases the survival in IgG3 deficient mice.
Minor concerns and questions:
￿ It is known that IgG3-deficient mice in BALB/c
background are more susceptibleto pneumococcal infec-
tion than wild-type BALB/c mice. In this study, did the
authors observe any infection by commensal bacteria or
any evidence of inflammatory bowel disease in IgG3
deficient mice?
￿ In Figure 1B, the signs “ +/+, +/- and -/-” are not
aligned with the gel lanes properly.
The manuscript can be accepted for publication in
“Biology Direct” provided that the authors perform the
suggested experiment.
Authors’ responses to reviewer 1 (Pandiyan)
The experiments requested by the reviewer were done
many years ago and reported in multiple publications,
two of which are cited as references 13 and 14 in our
manuscript.
In the present study, we did not investigate infections
or the possible presence of inflammatory bowel disease.
Such matters are beyond the scope of the present study.
Comments on once-revised manuscript - reviewer 1
(Pandiyan)
Antibodies of the IgG3 subclass are previously known to
play a role in the pathogenesis of the spontaneous glo-
merulonephritis in MRL/MpJ-Tnfrsf6lpr (MRL/lpr)
mice. However, as put forward by the authors, the ratio-
nale of the current study is to provide a direct and a
more definitive evidence that IgG3 antibodies are
important in the spontaneous renal disease of MRL/lpr
mice, using mice with genetic deficiency in the capacity
to synthesize IgG3 antibodies. In order to validate the
direct pathological role of IgG3, the authors must per-
form the passive transfer of the antibodies in their
mouse model. I agree that it has been previously shown
that passive transfer of IgG3 monoclonal antibodies can
elicit renal pathology analogous to the damage that
develops spontaneously in MRL/lpr mice. However as
authors argued, the serum levels of such antibodies
required for those effects may surpass those that are
physiologically relevant in the spontaneous disease.
Moreover those experiments were not performed in
mice that were specifically defective in IgG3 subclass
antibodies in MRL/lpr background. Therefore, the
authors must demonstrate a direct role of this subclass
of antibodies in the pathology in mice defective in IgG3
subclass antibodies in MRL/lpr background, which was
not done in the previous studies, cited as references 13
and 14. It is necessary to show that such a passive trans-
fer of physiological levels of IgG3 antibodies reverses
and reduces the longer life span, observed in the IgG3-
deficient MRL/lpr mice in their model. The manuscript
can be accepted for publication in “Biology Direct” pro-
vided that the authors perform this experiment.
Authors’ responses to reviewer 1 (Pandiyan) regarding
initially revised manuscript
While we agree with reviewer 1 that it would potentially
be useful to perform passive transfer experiments with
IgG3 antibodies in the IgG3-deficient MRL/lpr mouse
model, such experiments are not guaranteed to recreate
the in vivo conditions that obtain during the evolution
of spontaneous glomerulonephritis. It would take sub-
stantial effort to produce the relevant reagents (and we
do not know what, if any, antigen specificities these
antibodies would need to express), define the necessary
experimental parameters (e.g, the amounts of antibodies
and the duration of the period of administration), and
carry out the experiments. These efforts potentially
represent an amount of work sufficient for another
manuscript. Furthermore, neither of the other two
reviewers commented on the need for passive transfer
experiments to justify the publication of the present
manuscript. Therefore, we respectfully disagree with the
reviewer on this point.
Reviewer 2, Irun Cohen
The aim of the study was to provide direct evidence that
IgG3 isotype antibodies are critical in the glomerulitis
that develops in MRL/lpr mice. The method was to
backcross a ‘defective’ gamma3 heavy chain into MRL/
lpr mice and observe serum anti-dsDNA antibodies par-
ticularly of the IgG3 isotype; kidney lesions; IgG and
IgG3 eluted from the kidneys; kidney function and sur-
vival. The mice with the ‘defective’ gamma3 (termed -/-)
demonstrated a slight decrease in general serum IgG
anti-dsDNA with essentially no IgG3; less IgG and
much less IgG3 eluted from the kidneys; modified histo-
logic kidney pathology; and delayed death compared to
wild type (termed +/+) and heterozygous mice (termed
+/-).
I have several problems with the conclusions one may
draw from these results:
1. The so-called -/- mice are transgenic for a defective
gamma3 heavy chain; they are not gene knockouts, and,
in fact, IgG3 was eluted from their kidneys. Therefore,
they do produce at least some IgG3 antibody. So the
observations and results cannot be attributed to the
absence of IgG3 antibodies.
2. We are not given any details about the actual defect
in the transgene, or how expression of the defective
gene might have affected expression of the wild type
gene that was left, or ideas about the possible role of
IgG3 in the recognition of dsDNA, or the likely
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equivalent human IgG isotype (IgG2?) and their possible
roles in SLE in humans vs mice.
3. The mice with the defective IgG3 heavy chain gene
died, albeit later than their counterparts; was there any
effect of the transgene on the general lymphoprolifera-
tive disease of the mice? Did the transgene affect only
the kidneys? What actually killed the mice? I enjoyed
reading the paper; I found it to be thought provoking
and raised the issue of how a single gene product might
affect the pathophysiology of a complex immune system
and organ system disease.
Authors’ responses to reviewer 2 (Cohen)
The original gamma 3 heavy chain-deficient mice were
obtained by homologous recombination of the targeting
vector at the gamma 3 heavy chain locus (ref. 30 in the
manuscript). The SNP analysis, included for reviewers
only, strongly suggests that the defective gamma 3 heavy
chain allele inserted as intended eliminating the wild-
type allele and making the genetically-manipulated mice
true knockouts.
The targeting vector, as described in ref. 30, contained
a neomycin-resistance gene just upstream of the
sequence coding for CH1. This gene structure was
designed to be unexpressed.
The Western blot analysis of sera from mice posses-
sing the defective gamma 3 heavy chain allele in both
ref. 27 and the present manuscript support the inference
that if there is any IgG3 antibody in the sera of these
mice it is at a concentration below the level of detection
of this assay. In addition, in ref. 27 it was shown by ELI-
SPOT analysis that there were no spleen cells sponta-
neously secreting IgG3 (sensitivity approximately one
cell per million) in mice of the BALB/c background that
were genotyped as gamma 3 -/-. In contrast, spleens
from wild-type BALB/c mice contained numerous cells
secreting IgG3.
Mouse IgG3 and human IgG2 are not fully ‘equiva-
lent,’ although both isotypes are associated with
responses to polysaccharide immunogens. Human IgG2
has not been described to dynamically self-associate
non-covalently like murine IgG3, but Yoo et al. (J
Immunol. 2003 Mar 15;170(6):3134-8. PubMed PMID:
12626570) have described IgG2 dimers that form due to
disulfide bonds between Fc regions of otherwise separate
IgG monomers.
Reviewer 3, Etienne Joly
The manuscript by Greenspan et al. describes that,
when an inactivated IgG3 locus is introgressed in MLR/
lpr mice those become partially protected against
glomerulomephritis.
On the positive side, I found the observations reported
convincing, and those could clearly be relevant to deci-
phering the pathogenesis of kidney damage in lupus,
and other antibody-mediated diseases.
On the other hand, although the overall quality of the
English was more than adequate, I also found that many
aspects of the work were very poorly presented, and this
was particularly true for the material and methods and
the results sections. I would therefore strongly suggest
that many modifications should be made to the manu-
script before it is published. Below, I have provided a
non exhaustive list of suggestions, but I would also
advise the authors to seek advice from willing colleagues
inside and outside of their immediate field of study to
help them improve the overall structure and contents of
their manuscript.
1) Nowhere in the title or abstract does it say that
MRL/lpr mice are a commonly used model for SLE. In
fact, I would also suggest adding a bit more info on
these mice in the introduction, such as that provided at
the Jackson (http://www.informatics.jax.org/external/
festing/mouse/docs/MRL.shtml)
2) In the abstract, I suggest replacing the sentence
“gamma3 -/- mice exhibited minimal titers of these
auto-antibodies “ by “gamma3 -/- mice exhibited base-
line levels of these auto-antibodies"; Indeed, ‘minimal
titers’ suggests that there are some IgG3 still present,
and according to McLay et al. 2002, the IgG3 KO mice
h a v eac o m p l e t ea b s e n c eo fI g G 3s y n t h e s i s .A n ys i g n a l
detected should be due either to background noise, or
cross reactivity of the reagents on other isotypes.
3) In the introduction, in the sentence “In terms of
IgG subclasses, there is evidence implicating both IgG2a
and IgG3 antibodies in the pathogenesis of renal disease
[6]“ you should specify whether this is true for humans,
mice, or both
4) further down, I would change ‘Subsequent reports
revealed that many IgG3 antibodies self-associate in
antigen-independent [16-20]’ to ‘Subsequent reports
revealed that a specific particularity of many IgG3 anti-
bodies is to self-associate in antigen-independent
[16-20]’
5) In the section on genotypes of mice in the M&M,
there should be a much more thorough description of
the IgG3 +/- genotyping protocol, with a reference to
panel A of Figure 1. In fact, it may be best to describe
the whole of Figure 1 in the M&M. The SNP genotyp-
ing should then be presented as a separate paragraph
(or section even) Since the Fas locus is very important
in the MRL/lpr phenotype, it would also be good to
underline that this region is indeed correctly from the
MRL origin. There is also a typo on the last line: table,
not tabel.
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specific for double-stranded (ds) DNA and g-actinin, I
am not exactly sure of what the purpose of the passage
of dsDNA through a 0,45 micron filter is. It is possibly
to sterilize it, and/or to shear the DNA, but certainly
not to purify it !
7) In the section “Elution of antibodies from kidneys":
the buffer(s) used, and the precise conditions should be
specified ( volumes, temperature, time, shaking or
not...). Also, I suggest changing ‘The total eluted IgG or
IgG3 in each group was determined ...’ to ‘The amounts
of eluted IgG or IgG3 in each group were determined
...’. On this same subject, in the results section, the
amounts of antibodies eluted are expressed as concen-
trations, which really does not mean anything if one
does not know the final volume used for elution. I
would strongly suggest expressing those as total
amounts of antibody per kidney, or per mouse.
8) Evaluation of renal structure: Upon sacrifice (at
specific ages selected to provide insight into ( not to)
the progression
9) I suggest that the first paragraph of the results
really belongs in the M&M section. The layout of Figure
1 has also gone wrong( lane legends are nto aligned
with picture), but I suspect this has happened during
the submission process. As a whole, however, I found
that the layout of figures was really awkward, and not
bearing in mind that those would be printed as a very
small fraction of a page in the final pdf. Blank areas
should thus be kept to a minimum, and important infor-
mation presented in a way that can sustain shrinking
(such as the picture of the gel on Figure 1)
10) On Figure 3, I find it really bizarre not to have the
percentages of normal Balb/C mice. As it is, how do we
know that the low percentage of DN is not an effect of
the IgG3-/- specific to the Balb/c background?
11) In the text describing Figure 4, I would replace
‘minimal levels’ by ‘baseline levels’. The last sentence of
that sections is completely out of place here: you have
not made any previous mention of differences in renal
function in the -/- mice yet !!
12) In the section on eluted antibodies: as mentioned
earlier, these need to be expressed as total amounts (in
micrograms) per kidney or mouse. You also need to
describe how the ratios between total IgG and IgG3
were established. The most disturbing thing to me, how-
ever, was that these data were not presented as a figure.
Is this because this was done only once or twice (which
would explain why there is not deviation provided)? If it
is the case, you should really repeat this a few more
times instead of providing data in this shoddy format
which is both difficult to apprehend, and does not cor-
respond to data which had been documented sufficiently
thoroughly.
13) Regarding figure plots, I would strongly encourage
you to convert them to a smaller format with white
backgrounds. Figures 4, 5, 6 and the data on eluted anti-
bodies could then all be presented on a single figure
with 4 small panels.
14) I would like to express my very strong disagree-
ment (not to say outrage) regarding the following sen-
tences: “"Serum creatinine in both the +/+ and +/- mice
at 26 weeks was significantly (t > 3.6, p < 0.01) higher
than the level in the same genotype at 18 weeks,
whereas the difference in serum creatinine between 18
and 26 week old -/- mice was not significant (t = 2.2).
These data indicate that there was progressive renal
insufficiency (and presumably nephron loss) in the mice
capable of producing IgG3, but not in -/- mice.”. Indeed,
just because a difference does not reach statistical signif-
icance, it does not mean that there is no difference. I
would thus suggest the following wording: “Serum crea-
tinine in both the +/+ and +/- mice at 26 weeks was sig-
nificantly (t > 3.6, p < 0.01) higher than the level in the
same genotype at 18 weeks, whereas the difference in
serum creatinine between 18 and 26 week old -/- mice
was less pronounced and did not reach statistical signifi-
cance (t = 2.2). These data thus suggest that there was
progressive renal insufficiency (and presumably nephron
loss) in the mice capable of producing IgG3, but that
this was attenuated in -/- mice.”
15) I found the whole section on histopathology extre-
mely difficult to read and understand. Indeed, whereas,
in other sections of the manuscript a clear effort is
made to be didactic for a non specialist reader ( which
is commendable since Biology Direct is not a specialty
journal), I found that this section was incredibly difficult
to decipher. I would actually suggest pooling Figures 7
and 8, and placing the actual titles next to each of the
histology panels rather than letters, to make it clear that
those are provided as examples, and not representative
of mice of one or another genotype. And once the
manuscript has been modified, I would strongly urge
you to seek the assistance of colleagues outside the field
to help make this section into something that is more
easy to understand for people like me.
16) Regarding Figure 9, it took me a while to convince
myself that the data for all three groups of mice had
been pooled. This is simply not an appropriate proce-
dure ! I suspect that, once again, this was due to the
fact that you did not have sufficient numbers of mice in
each group to plot the survival curves independently for
each group, and looking at the curves, it seems to have
been due to a lack of females, most probably because
those had been needed to breed to maintain the colony
and generate more mice. In this kind of situation, where
you have made the observation over and over again, but
do not have the right numbers of mice in each group, I
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in the text that, as in the MRL/lpr parental strain, you
did not detect any gender effect in any of the back-
crossed groups.
17) In the discussion, the idea about an IgG3 rheuma-
toid factor is interesting, but it would be helpful to
define clearly what a rheumatoid factor is (i.e. an anti-
body that can bind to the Fc portion of other
antibodies).
18) Further down, replace “with the notion that elimi-
nation of IgG3 antibodies attenuates the irreversible
renal damage associated with the MRL/lpr mouse
strain.” by “with the notion that the absence of IgG3
antibodies attenuates the irreversible renal damage asso-
ciated with the MRL/lpr mouse strain.”
Authors’ responses to reviewer 3 (Joly)
1) The abstract now notes that the MRL/lpr strain has
been widely studied as a model of human systemic
lupus erythematosus.
2) The requested wording change in the abstract has
been implemented.
3) The relevant sentence (p. 4) now indicates that the
reference to Ig3 and IgG2a antibodies applies to mice.
Humans do not have a subclass referred to as “IgG2a.”
4) The relevant passage (Introduction, paragraph 3)
has been modified to read as follows: “Subsequent
reports revealed that a notable characteristic of many
IgG3 antibodies is to self-associate in antigen-indepen-
dent [16-20] or antigen-dependent [21-24] contexts.”
5) In the M&M section on “Genotypes of mice,” refer-
ence is now made to Figure 1. As suggested, we have
also moved the sentences about the SNP typing to a
separate section with a sub-heading, and the implica-
tions of the SNP analysis for the allelic origins of the
g e n e sa tt h eF a sl o c u so nc h r o m o s o m e1 9a r en o w
explicitly noted in the appropriate subsection in the
Results (p. 9). The typographical error in the last line of
what is now the “Genomic SNP analysis” section has
been fixed.
6) Passage through the 0.45 micron filter is to remove
the single stranded DNA, thus enriching for dsDNA.
This is a standard method which has been used in all of
our (CP) previous relevant publications, and it has never
been questioned.
7) The wording changes requested have been imple-
mented in the M&M section on the methods for elution
of IgG antibodies from kidneys. As requested, details of
the methods have also been inserted.
8) The requested revision in the text has been imple-
mented in the M&M section on “Evaluation of renal
structure.”
9) For the gel photograph in Figure 1, we have substi-
tuted single-letter abbreviations (w - wild-type; k -
knockout; h - heterozygote; m - markers) which we hope
will better preserve alignment with the correct lanes
throughout the submission and publication process.
10) We have reduced Figure 3 to one panel focused
on T-cell subsets. The data presented are from an
experiment in which spleen cells from wild-type C3H
mice were used for comparison to the spleen cells from
MRL/lpr mice of all three g3 genotypes (+/+, +/-, -/-).
Similar results were obtained in a repeat experiment
with spleen cells from BALB/c g3 -/- mice.
11) The requested revision has been made (Results,
paragraph 4; “minimal levels” replaced by “baseline
levels”). In addition, we have modified the wording of
the final sentence of the section to read: “The greater
concentration of the IgG3 auto-antibodies in the IgG3
producing mice could contribute to any observed g3
genotype-associated differences in renal function, renal
histopathology, and survival (see below).”
12) See response to comment 7.
13) We acknowledge the reviewer’s comment but do
not believe it is necessary to consolidate the figures or
create a figure for the limited kidney elution data.
14) We have implemented requested change in word-
ing in paragraph 7 of Results.
15) As suggested, the first paragraph of the section has
been significantly revised.
16) As suggested, we have eliminated Figure 9B and
now refer to the corresponding results in the text.
17) A description of rheumatoid factors has been
inserted, as requested, in paragraph 4 of the Discussion.
18) We have replaced “elimination” with “the absence”
in paragraph 5 of the Discussion.
Comments on once-revised manuscript - reviewer 3 (Joly)
The manuscript by Greenspan et al. describes that,
when an inactivated IgG3 locus is introgressed in MLR/
lpr mice those become partially protected against glo-
merulomephritis. I found the observations reported con-
vincing, and those could clearly be relevant to
deciphering the pathogenesis of kidney damage in lupus,
and other antibody-mediated diseases.
Compared to the initial version, I find that the modifi-
cations introduced following the suggestions of the
three referees have resulted in a very significant
improvement of the manuscript.
I do, however, remain thoroughly unsatisfied with the
aspects dealing with elution of immunoglobulins from
kidneys, for the following reasons:
- The authors only provide the concentrations of anti-
bodies recovered, but not the total volumes of those elu-
a t e s .T h e r ei sn o te v e na ni n d i c a t i o nt h a tt h es a m e
volumes were used for all samples. What should really
be provided, and compared, are amounts of antibodies
per kidney (or per mg of tissue).
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have come to suspect very strongly that these data were
obtained only once, with each value corresponding to
one eluate obtained from the pooled half-kidneys in
each of the cohorts. I can understand that this may be
an unavoidable limitation of the approach, but this
should have been made very clear, and justified, in the
text.
- In this paragraph, the authors state that “< 12% of
the IgG in eluates from -/- mice was IgG3.”,s u g g e s t i n g
that there are some IgG3 to be found in IgG3 KO mice.
According to McLay et al. 2002 (ref 27), however, the
IgG3 KO mice have a complete absence of IgG3 synth-
esis. Any signal detected would thus be due either to
background noise, or cross reactivity of the reagents on
other isotypes.
- And what to say of the +/- mice, for which ‘IgG3
represented ~10% of the total IgG eluted’,i . e .r o u g h l y
the same levels as those from IgG3 KO mice?
- All those considerations are particularly relevant
since, contrary to what the authors state, the differences
in total IgG concentrations between +/+ and -/- mice
are actually rather minor: 16.8 vs 6 μg/ml at 18 weeks,
and 86 vs 66 μg/ml at 21 weeks. From what I can make
out from the data in the form in which it is provided,
the IgG deposits are mostly of the IgG3 subtype in +/+
mice, and not so much less, but of other subtypes in -/-
mice, and very surprisingly also in +/- mice. This last
point is completely brushed over by the authors. This
observation in itself underlines the need for those
experiments to be repeated on additional mice, or
cohorts of mice, before those results can be considered
as sound and reliable.
I was also sorry to see that the authors had chosen to
ignore my suggestions on two much less important
points:
- In the paragraph of the M&M section about anti
d s D N AE L I S A ,It h o u g h tt h a ti tw o u l db eh e l p f u lt o
clarify that the purpose of passing the DNA through a
0.45 micron filter was to eliminate single stranded DNA.
- I also suggested that the layout of figures should be
modified. As they are now, I suspect that those figures
will become extremely difficult to read once they have
been reduced to printing sizes, and will become comple-
tely useless to people if printed in black and white (as
well as for color-blind people).
Authors’ responses to reviewer 3 (Joly) regarding initially
revised manuscript
We now explicitly state in the relevant section of Mate-
r i a l sa n dM e t h o d st h a tt h ek i d n e ye l u t i o n sw e r eo n l y
performed once. As for the methodology, the identical
volumes of fluid were used for eluting each kidney. We
believe that the apparent IgG3 concentrations eluted
from the g3 -/- kidneys most likely arose from the cross-
reactivity of the detection reagent for the ELISA.
As requested, we have added the rationale for the fil-
t r a t i o no ft h eD N At ot h es e c t i o no nt h eE L I S Af o r
autoantibodies specific for dsDNA in Materials and
Methods.
Although we appreciate the reviewer’ss u b s t a n t i a l
efforts in reviewing the manuscript and take seriously
his suggestions (as demonstrated by implementing
almost all of them), we are not convinced that it will be
a net benefit to modify the figures.
List of abbreviations
MRL/lpr : MRL/MpJ-Tnfrsf6lpr; dsDNA: double-stranded DNA; SNP: single-
nucleotide polymorphism;
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